Both in Pharmaceuticals
Neuphoria Therapeutics vs Atossa Therapeutics
Over the past year NEUP returned −69.9% and ATOS returned −84.8%; their daily moves had a correlation of 0.10.
NEUP −69.9% ATOS −84.8%Growth of $1, one year, split-adjusted
| Metric | NEUP | ATOS |
|---|---|---|
| Price | $3.57 | $1.99 |
| Market cap | $19.3M | $19.9M |
| Today | −2.19% | +1.53% |
| 1 month | −5.1% | −22.9% |
| 6 months | −9.4% | −57.7% |
| Year to date | −8.0% | −77.5% |
| 1 year | −71.0% | −84.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $26.1M |
| Dividend yield | — | — |
| Volatility (60d) | 44.8% | 63.4% |
| Short % of float | 0.5% | 8.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).